Revenue - ESSA Pharma Inc (NASDAQ:EPIX) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 6.32 USD -5.95%

Updated:

ESSA Pharma Inc
Revenue

Last Value

3-Years CAGR

5-Years CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

ESSA Pharma Inc
Revenue Peer Comparison

ZYME

FUSN

AUPH

SBFM

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	ESSA Pharma Inc NASDAQ:EPIX	Revenue $0	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Zymeworks Inc NYSE:ZYME	Revenue $76m	CAGR 3-Years 25%	CAGR 5-Years 7%	CAGR 10-Years N/A
	Fusion Pharmaceuticals Inc NASDAQ:FUSN	Revenue $2.1m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Revenue $175.5m	CAGR 3-Years 52%	CAGR 5-Years 223%	CAGR 10-Years 68%
	Sunshine Biopharma Inc OTC:SBFM	Revenue $24.1m	CAGR 3-Years 601%	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Revenue amounts to 0 USD.

Join more than 129,400+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.